2022 annual financial data
MiNK Therapeutics 2022 Net margin
Direct answer
Net margin was -1.03%.
Operating income was -30,949,278 USD and net income was -27,991,212 USD.
Operating cash flow was -18,866,843 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,704,743,000 USD
- Operating income
- -30,949,278 USD
- Net income
- -27,991,212 USD
- Operating cash flow
- -18,866,843 USD